Norway· NO-ID_DF4C220A-1155-4920-BA00-51E493E787B3
Evkeeza
A evinacumab product containing evinacumab, registered in Norway by Ultragenyx Germany GmbH. The same ATC class is registered in 12 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Evinacumab is registered in 12 of 19 countries.
Countries holding a registration under ATC C10AX17 (evinacumab), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 8 of them publish a price we can compare per daily dose
Evinacumab · ATC C10AX17
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Evinacumab
- Manufacturer
- Ultragenyx Germany GmbH
- Country
- Norway (NO)
- ATC code
- C10AX17
- ATC class
- Evinacumab
- Defined daily dose
- 37.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_DF4C220A-1155-4920-BA00-51E493E787B3
- no_varenummer1653001 x 2.3NOK 103713.4
- gtin4062343002070
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Evinacumab in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumEvkeeza 150 mg/mlUltragenyx Germany
- CzechiaEVKEEZAUltragenyx Germany GmbH, Berlín
- United StatesEvkeezaRegeneron Pharmaceuticals, Inc.
- IrelandEvkeeza 150 mg/ml concentrate for solution for infusionUltragenyx Germany GmbH
- IcelandEvkeezaUltragenyx Germany GmbH
- PolandEvkeezaUltragenyx Germany GmbH
- SwedenEvkeeza 150 mg/ml Koncentrat till infusionsvätska, lösningUltragenyx Germany GmbH
- FinlandEvkeezaUltragenyx Germany GmbH
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Evkeeza
- Liechtenstein · Evkeeza
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8bc4de47-2612-4d8e-ad72-fa34ef15e88e GET /v1/drugs/8bc4de47-2612-4d8e-ad72-fa34ef15e88e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Konsentrat til infusjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Evinakumab",
"merkevare_id": "ID_DF4C220A-1155-4920-BA00-51E493E787B3",
"name_form_strength": "Evkeeza kons til inf oppl 150 mg/ml",
"prescription_group": "C"
}See everything about evinacumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.